These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37920923)

  • 1. Prospective study of cenobamate on cognition, affectivity, and quality of life in focal epilepsy.
    Catalán-Aguilar J; Hampel KG; Cano-López I; Garcés M; Lozano-García A; Tormos-Pons P; González-Bono E; Villanueva V
    Epilepsia Open; 2024 Feb; 9(1):223-235. PubMed ID: 37920923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Add-on treatment with cenobamate is already effective at low doses in refractory focal epilepsy: A prospective observational study.
    Novitskaya Y; Schütz E; Metternich B; Schulze-Bonhage A; Hirsch M
    Epilepsia; 2024 Mar; 65(3):630-640. PubMed ID: 38135903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spanish consensus on the management of concomitant antiseizure medications when using cenobamate in adults with drug-resistant focal seizures.
    Carreño M; Gil-Nagel A; Serratosa JM; Toledo M; Rodriguez-Uranga JJ; Villanueva V
    Epilepsia Open; 2024 Jun; 9(3):1051-1058. PubMed ID: 38573131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Cenobamate on Cognition in Patients with Drug-Resistant Epilepsy with Focal Onset Seizures: An Exploratory Study.
    Serrano-Castro PJ; Ramírez-García T; Cabezudo-Garcia P; Garcia-Martin G; De La Parra J
    CNS Drugs; 2024 Feb; 38(2):141-151. PubMed ID: 38265735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reductions in concomitant antiseizure medication drug load during adjunctive cenobamate therapy: Post-hoc analysis of a subset of patients from a phase 3, multicenter, open-label study.
    Aboumatar S; Ferrari L; Stern S; Wade CT; Weingarten M; Connor GS; Rosenfeld WE
    Epilepsy Res; 2024 Feb; 200():107306. PubMed ID: 38340681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of six new antiseizure medications for adjunctive treatment of focal epilepsy and epileptic syndrome: A systematic review and network meta-analysis.
    Tong J; Ji T; Liu T; Liu J; Chen Y; Li Z; Lu N; Li Q
    Epilepsy Behav; 2024 Mar; 152():109653. PubMed ID: 38277848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of cenobamate for focal seizures in people with drug-resistant epilepsy.
    Laskier V; Agyei-Kyeremateng KK; Eddy AE; Patel D; Mulheron S; James S; Thomas RH; Sander JW
    Epilepsia; 2023 Apr; 64(4):843-856. PubMed ID: 36625423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cenobamate on cognitive performance of epilepsy patients.
    Schuetz E; Wagner K; Metternich B; Papadopoulou G; Kravalis K; Heers M; Martínez-Lizana E; Castillo-Rodriguez M; Altenmüller DM; Schulze-Bonhage A; Hirsch M
    Seizure; 2022 Nov; 102():129-133. PubMed ID: 36240699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive and psychiatric adverse events during adjunctive cenobamate treatment in phase 2 and phase 3 clinical studies.
    Krauss GL; Chung SS; Ferrari L; Stern S; Rosenfeld WE
    Epilepsy Behav; 2024 Feb; 151():109605. PubMed ID: 38184949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjunctive cenobamate in highly active and ultra-refractory focal epilepsy: A "real-world" retrospective study.
    Peña-Ceballos J; Moloney PB; Munteanu T; Doyle M; Colleran N; Liggan B; Breen A; Murphy S; El-Naggar H; Widdess-Walsh P; Delanty N
    Epilepsia; 2023 May; 64(5):1225-1235. PubMed ID: 36790345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Ex Vivo Evaluation of Cenobamate Administered via Enteral Tubes.
    Ferrari L; Nisman A; Pegan A; Ursino J
    Drugs R D; 2020 Jun; 20(2):125-133. PubMed ID: 32328931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Analysis of Cenobamate and Concomitant Anti-Seizure Medications in Human Plasma via Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry.
    Molteni L; Charlier B; Coglianese A; Izzo V; Assenza G; Menna P; de Grazia U; D'Urso A
    Molecules; 2024 Feb; 29(4):. PubMed ID: 38398636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of adjunctive cenobamate based on number of concomitant antiseizure medications, seizure frequency, and epilepsy duration at baseline: A post-hoc analysis of a randomized clinical study.
    Rosenfeld WE; Nisman A; Ferrari L
    Epilepsy Res; 2021 May; 172():106592. PubMed ID: 33662894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cenobamate: A New Adjunctive Agent for Drug-Resistant Focal Onset Epilepsy.
    Buckley CT; Waters OR; DeMaagd G
    Ann Pharmacother; 2021 Mar; 55(3):318-329. PubMed ID: 32623899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biocatalytic enantioselective synthesis of cenobamate, an antiepileptic drug.
    Haritha V; Deepthi P; Gundamalla R; Nagesh K; Satyanarayana SV; Rao AB; Balasubramanian S; Reddy BVS
    Chirality; 2024 Apr; 36(4):e23660. PubMed ID: 38511944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA).
    Falip M; López González FJ; Martín-Herranz I; Merino-Bohórquez V; Montoya J; Rey Gómez-Serranillos I; Rodriguez Uranga JJ; Ruiz E; Sancho-López A; Trillo Mata JL; Antoni Vallès J; Álvarez-Barón E; Sabaniego J; Subías-Labazuy S; Gil A
    Epilepsy Behav; 2023 Aug; 145():109350. PubMed ID: 37480633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Onset of efficacy and adverse events during Cenobamate titration period.
    Steinhoff BJ; Ben-Menachem E; Brandt C; García Morales I; Rosenfeld WE; Santamarina E; Serratosa JM
    Acta Neurol Scand; 2022 Sep; 146(3):265-275. PubMed ID: 35711112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive use of cenobamate for pediatric refractory focal-onset epilepsy: A single-center retrospective study.
    Varughese RT; Shah YD; Karkare S; Kothare SV
    Epilepsy Behav; 2022 May; 130():108679. PubMed ID: 35381496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive cenobamate for the treatment of focal onset seizures in adults with epilepsy: a critical review.
    Wheless JW
    Expert Rev Neurother; 2020 Nov; 20(11):1085-1098. PubMed ID: 33031714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post hoc analysis of a phase 3, multicenter, open-label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications.
    Rosenfeld WE; Abou-Khalil B; Aboumatar S; Bhatia P; Biton V; Krauss GL; Sperling MR; Vossler DG; Klein P; Wechsler R
    Epilepsia; 2021 Dec; 62(12):3016-3028. PubMed ID: 34633074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.